
About Rovi
Rovi is a publicly listed company based in Pozuelo De Alarcon (Spain) founded in 1946. Pharmaceutical products manufacturer and CDMO services provider. The company has 2,200 employees. Its chief executive, as recorded, is Juan Encina. Its website rovi.es draws about 17 thousand monthly visits. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Rovi was founded in 1946 as a pharmaceutical manufacturer and CDMO services provider. Operations include production of prescription drugs and hospital supplies, alongside contract services for prefilled syringes and oral solid forms. Focus is placed on biosimilars and low-molecular-weight heparin. Investments are made in research and development to support growth. A portfolio of own and licensed products is maintained across various categories.
- Annual Revenue$873.59 M (USD)-2.65as on Dec 31, 2025
- Net Profit$165.02 M (USD)2.6as on Dec 31, 2025
- EBITDA$239.14 M (USD)-1.55as on Dec 31, 2025
- Latest Funding Round$92.85M (USD), Post-IPO
Sep 2018
- Employee Count2,200
Funding Insights of Rovi
- Total Rounds 1
- Last Round Post-IPO β $92.85M
- First Round $92.85M
(Sep 2018)
All 1 funding rounds of Rovi with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2018 | $92.85M | Post-IPO | β | β | β |
People of Rovi
2 people are tracked at Rovi (2 in leadership); the tracked headcount is 2,200.
| Name | Role | Group |
|---|---|---|
Juan Encina | CEO | Leadership |
Javier Lopez Belmonte | Vice President & Chief Financial Officer | Leadership |
Complete people profiles for Rovi
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Rovi
Rovi is a publicly listed company on the BME with ticker symbol ROVI in Spain, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date05 Dec 2007
- Listed onBME: ROVI
- Listed entityLaboratorios Farmaceuticos Rovi, S.A.
- Exchange sectorHealth technology
- ISINES0157261019
- Share price58.35 EUR (+1.57% on the day) · 2026-10-14
- Market capitalisation2,905,136,067.00 EUR
- Price to earnings16.1
- EPS (diluted, trailing year)3.62 EUR
- Dividend yield1.35%
- Volume (last session)13,643
Financials of Rovi
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 743.5M EUR | 140.4M EUR | 203.5M EUR |
| 2024 | 763.8M EUR | 136.9M EUR | 206.7M EUR |
| 2023 | 829.5M EUR | 170.3M EUR | 243.8M EUR |
| 2022 | 817.7M EUR | 199.7M EUR | 276.6M EUR |
| 2021 | 648.7M EUR | 153.1M EUR | 203.1M EUR |
Detailed financial statements for Rovi
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Rovi
3 dated milestones of Rovi across 72 years, from founding to its latest funding, stage changes and deals.
- Founded Rovi is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $92.8M.
Web traffic of Rovi
The website of Rovi (rovi.es) receives about 17.2K visits a month and ranks #1,303,574 among all websites worldwide, #1,674 in Biotechnology and Pharmaceuticals.
- Monthly visits17.2K
▼ 17.7% vs previous month
- Unique visitors8.7K
per month
- Global rank#1,303,574
among all websites
- Category rank#1,674
Health · Biotechnology and Pharmaceuticals
- Bounce rate43%
- Pages per visit1.8
- Average visit1 min 04 sec
- DevicesDesktop 27% Β· Mobile 73%
Websites whose visitors overlap most with Rovi. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| reigjofre.com | 100% | 5.1K | #3,405,973 | View details | |
| arkopharma.com | 97% | 220.4K | #215,630 | View details | |
| servier.com | 93% | 306.8K | #150,173 | View details | |
medinfar.pt | medinfar.pt | 93% | #1,731,584 | β | |
| cinfa.com | 76% | 640.7K | #105,172 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 24 similar websites and full traffic analytics for Rovi
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 24 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Rovi
Complete news archive for Rovi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rovi
Rovi was founded in 1946 and raised its 1st funding round 72 years after it was founded.
Rovi is headquartered in Pozuelo De Alarcon, Spain. It is registered at Pozuelo De Alarcon, Madrid, Spain.
Juan Encina is the CEO of Rovi, as recorded in our data.
Rovi has 2,200 employees.
Annual revenue of Rovi is $873.59M as on Dec 31, 2025.
Rovi was founded in 1946 as a pharmaceutical manufacturer and CDMO services provider. Operations include production of prescription drugs and hospital supplies, alongside contract services for prefilled syringes and oral solid forms. Focus is placed on biosimilars and low-molecular-weight heparin. Investments are made in research and development to support growth. A portfolio of own and licensed products is maintained across various categories.
Yes, Rovi is publicly traded on BME under the ticker symbol ROVI.
